Article Details

U.S. FDA approves new Bristol Myers cancer immunotherapy | Reuters

Retrieved on: 2022-03-19 07:26:46

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA approves new Bristol Myers cancer immunotherapy | Reuters. View article details on HISWAI: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-new-bristol-myers-cancer-immunotherapy-2022-03-18/

Excerpt

Hirawat said LAG-3 inhibitors like relatlimab can reinvigorate the immune system by restoring the function of "exhausted" T cells - a key ...

Article found on: www.reuters.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up